Sherry Ansher is the Associate Chief, Agreement Coordination Group, Regulatory Affairs Branch in the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, NCI. Dr. Ansher joined CTEP in 1994 after spending a year in the Grants Associates Program of the NIH as the Coordinator of Research and Development Agreements. She is responsible for all of the collaborative agreements for the clinical and nonclinical development of potential anticancer agents by CTEP and the interactions between the investigators, CTEP and the collaborating pharmaceutical companies. Dr. Ansher has a B.S. in biochemistry from the University of Maryland and a Ph.D. from Johns Hopkins University in biochemical pharmacology. Prior to joining NCI, Dr. Ansher worked at the Center for Biologics Evaluation and Research, FDA for 5 years and did her post doctoral training at the National Institute of Digestive Disorders and Kidney Disease, NIH.